Suppr超能文献

相似文献

1
Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era.
Nat Commun. 2022 Aug 19;13(1):4879. doi: 10.1038/s41467-022-32404-y.
8
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
Lancet. 2021 Nov 13;398(10313):1825-1835. doi: 10.1016/S0140-6736(21)02276-5. Epub 2021 Oct 28.

引用本文的文献

1
Leaky or polarised immunity: Non-Markovian modelling highlights the impact of immune memory assumptions.
PLoS Comput Biol. 2025 Aug 19;21(8):e1013399. doi: 10.1371/journal.pcbi.1013399. eCollection 2025 Aug.
2
A network-based model to assess vaccination strategies for the COVID-19 pandemic by using Bayesian optimization.
Chaos Solitons Fractals. 2024 Apr;181. doi: 10.1016/j.chaos.2024.114695. Epub 2024 Mar 14.
3
Comparative evaluation of behavioral epidemic models using COVID-19 data.
Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2421993122. doi: 10.1073/pnas.2421993122. Epub 2025 Jun 12.
5
Planning and adjusting the COVID-19 booster vaccination campaign to reduce disease burden.
Infect Dis Model. 2024 Sep 12;10(1):150-162. doi: 10.1016/j.idm.2024.09.002. eCollection 2025 Mar.
6
Effects of mobility, immunity and vaccination on SARS-CoV-2 transmission in the Dominican Republic: a modelling study.
Lancet Reg Health Am. 2024 Aug 30;37:100860. doi: 10.1016/j.lana.2024.100860. eCollection 2024 Sep.
7
Mathematical Modeling of SARS-CoV-2 Omicron Wave under Vaccination Effects.
Computation (Basel). 2023 Feb;11(2). doi: 10.3390/computation11020036. Epub 2023 Feb 15.
8
Recent approaches in computational modelling for controlling pathogen threats.
Life Sci Alliance. 2024 Jun 21;7(9). doi: 10.26508/lsa.202402666. Print 2024 Sep.
9
Modelling COVID-19 Vaccination in the UK: Impact of the Autumn 2022 and Spring 2023 Booster Campaigns.
Infect Dis Ther. 2024 May;13(5):1127-1146. doi: 10.1007/s40121-024-00965-8. Epub 2024 Apr 25.
10
Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States.
Ann Intern Med. 2024 May;177(5):609-617. doi: 10.7326/M23-2451. Epub 2024 Mar 26.

本文引用的文献

3
COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England.
Lancet Infect Dis. 2022 Jul;22(7):931-933. doi: 10.1016/S1473-3099(22)00309-7. Epub 2022 May 24.
4
Estimating disease severity of Omicron and Delta SARS-CoV-2 infections.
Nat Rev Immunol. 2022 May;22(5):267-269. doi: 10.1038/s41577-022-00720-5.
6
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.
N Engl J Med. 2022 Apr 21;386(16):1532-1546. doi: 10.1056/NEJMoa2119451. Epub 2022 Mar 2.
7
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines.
N Engl J Med. 2022 Jan 27;386(4):340-350. doi: 10.1056/NEJMoa2115481. Epub 2022 Jan 12.
8
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis.
Lancet Microbe. 2022 Jan;3(1):e52-e61. doi: 10.1016/S2666-5247(21)00267-6. Epub 2021 Nov 15.
10
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.
Nat Med. 2021 Jul;27(7):1205-1211. doi: 10.1038/s41591-021-01377-8. Epub 2021 May 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验